Sanara MedTech appoints Seth Yon as CEO; Nixon remains Executive Chairman

Sanara MedTech Inc.

Seth Yon promoted from President/Chief Commercial Officer to President/CEO and director, effective Sept 15, 2025.
Ron Nixon resigns as CEO but remains Executive Chairman; receives director retainer ($90K stock + $40K cash) plus $100K cash for Chairman role.
Yon employment agreement: $600K base salary, up to 100% bonus/stock awards, plus $1M one-time restricted stock grant vesting over 3 years.
Ashley Mackey designated principal accounting officer; Elizabeth Taylor remains CFO but no longer principal accounting officer.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.